203 related articles for article (PubMed ID: 11450170)
1. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
Manji HK; Moore GJ; Chen G
Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
[TBL] [Abstract][Full Text] [Related]
2. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
3. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers.
Manji HK; Moore GJ; Chen G
Br J Psychiatry; 2001 Jun; 178(Suppl 41):S107-19. PubMed ID: 11388949
[TBL] [Abstract][Full Text] [Related]
4. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
Einat H; Chen G; Manji H
Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099
[TBL] [Abstract][Full Text] [Related]
5. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
6. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.
Lenox RH; Wang L
Mol Psychiatry; 2003 Feb; 8(2):135-44. PubMed ID: 12610644
[TBL] [Abstract][Full Text] [Related]
8. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
Chen G; Manji HK
Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
[TBL] [Abstract][Full Text] [Related]
9. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
Gould TD; Quiroz JA; Singh J; Zarate CA; Manji HK
Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
[TBL] [Abstract][Full Text] [Related]
10. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes.
Stoll AL; Severus WE
Harv Rev Psychiatry; 1996; 4(2):77-89. PubMed ID: 9384977
[TBL] [Abstract][Full Text] [Related]
11. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
Manji HK; Chen G
Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995
[TBL] [Abstract][Full Text] [Related]
12. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
13. [On the relevance of protein kinase C to lithium therapy in bipolar disorder].
Sela B
Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097
[TBL] [Abstract][Full Text] [Related]
14. [Neuroprotective actions of lithium].
Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
[TBL] [Abstract][Full Text] [Related]
15. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness.
Manji HK; Lenox RH
Biol Psychiatry; 1999 Nov; 46(10):1328-51. PubMed ID: 10578449
[TBL] [Abstract][Full Text] [Related]
16. Valproate and neuroprotective effects for bipolar disorder.
Atmaca M
Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
[TBL] [Abstract][Full Text] [Related]
17. Lithium neuroprotection: molecular mechanisms and clinical implications.
Rowe MK; Chuang DM
Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
[TBL] [Abstract][Full Text] [Related]
18. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
[TBL] [Abstract][Full Text] [Related]
19. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
20. Kinases as drug targets in the treatment of bipolar disorder.
Catapano LA; Manji HK
Drug Discov Today; 2008 Apr; 13(7-8):295-302. PubMed ID: 18405841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
